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Introduction
Dose-response experiments are routinely conducted in preclinical and Phase I and II clinical trials to study the relationship between the dose level of a drug and the probability of a response, be it "cured" or "poisoned". The underlying assumption for quantal bioassay is that a subject is administered a stimulus at a dose level, say x, and that the response Y is a binary random variable with success probability p(x), i.e. Y ∼ Bin (1, p(x) ). The function p : R → [0, 1] is called the dose 1 response curve and is usually assumed to be strictly monotone. For a given α ∈ (p(0), p(1)) the parameter of interest is the effective dose level ED α = p −1 (α), (1.1) which is the dose, where 100α% of the subjects react. If n subjects are investigated at dose levels, say x 1 , . . . , x n , the statistical model is given by . . . , n, (1.2) where different observations are assumed to be independent and the aim of the experiment is to estimate the effective dose level ED α for a particular α ∈ (p(0), p(1)). There are two basic approaches for this purpose, a parametric and nonparametric method. The first approach assumes a parametric form for the dose response curve, say p(x) = p(x, θ) for some θ ∈ R k , and the unknown parameters are usually estimated by the maximum likelihood method. An estimate of the effective dose level is finally obtained by evaluating the inverse function p −1 (α,θ). The most widely used models are the probit and the logit model for p [see Berkson (1944) and Bliss (1934) ], other models are the double exponential, the double reciprocal and the skewed logit model [see e.g. McCullagh and Nelder (1983) ]. However, in many cases a parametric form of the dose response curve is not known by the experimenter, because the biological mechanisms are too complicated. In such cases the misspecification of a parametric model may lead to serious errors in the subsequent data analysis. For this reason numerous authors propose to estimate the effective dose level nonparametrically. Early proposals mainly for the purpose of estimating the ED 0.5 nonparametrically can be found in Spearman (1908) and Thompson (1947) . More recently Schmoyer (1984) constructed a constrained maximum likelihood estimator under the assumption that the dose response curve p is sigmoid, while Müller and Schmitt (1988) proposed a kernel estimator for the dose response curve p. Because this estimate is not necessarily strictly monotone, it was first monotonized [see Barlow, Bartholomew, Bremner and Brunk (1972) ] and the estimate of the effective dose level was then obtained by inversion according to (1.1). In this note we discuss a more direct approach for the estimation of the effective dose levels. Our work is motivated by the search of a monotone estimate of the ED α , which is not based on a constrained optimization and the inversion of the estimated dose response curve. For this purpose we construct a density estimate from the estimated dose response curve and use this additional smoothing step to obtain a monotone estimate of the effective dose level function directly. The estimate is carefully described in Section 2, where we also discuss its main properties. In particular we prove asymptotic normality of the estimate for p −1 and show that the new estimator is asymptotically first order equivalent to the estimate proposed by Müller and Schmitt (1988) . Moreover, the calculation of the new estimate is substantially simpler than the currently available methods. In Section 3 we study some of the finite sample properties of our estimator by means of a simulation study and demonstrate that our new estimate is at least comparable to the currently available nonparametric estimates of the effective dose level. All technical details are deferred to an appendix. We finally note that our approach has several advantages compared to the indirect methods proposed in the literature. The new procedure is based on a simple combination of a density and regression estimate. It is computational efficient and attractive to users of conventional kernel methods, 2 because it does not require any constrained optimization techniques or inversion. Moreover, the indirect methods do not necessarily allow the estimation of the effective dose level ED α for any α ∈ (p(0), p(1)), because it is not guaranteed that the inverse of the estimated dose response curve is defined for all α ∈ (p(0), p(1)). Finally, the new estimator has an asymptotic normal distribution, which allows a very simple construction of asymptotic confidence intervals for the ED α , whenever α ∈ (p(0), p(1)).
Monotone quantile estimation
Consider the binary response model (1.2), where different observations are assumed to be independent and the dose response curve p is assumed to be strictly increasing and two times continuously differentiable. For the experimental design x 1 < . . . < x n we assume without loss of generality
for a positive two times continuously differentiable design density f [see Sacks and Ylvisaker (1970) ]. The nonparametric estimate of the effective dose level curve is defined bŷ
) is the local linear estimator at the point
[see Wand and Jones (1995) or Fan and Gijbels (1996) ]. In (2.2) and (2.3) K d and K r denote symmetric kernels with compact support, say [−1, 1], existing second moment and h d , h r are the corresponding bandwidths converging to 0 with increasing sample size n. We also assume that K d is two times continuously differentiable and positive. The indices "r" and "d" correspond to the phrase "regression" and "density" because we combine a regression with a density estimate to define the estimator in (2.2). For the sake of transparency we restrict ourselves to the local linear estimate, but it is notable that all results of the paper remain valid (subject to an appropriate modification of constants) for other types of kernel estimators as the Gasser-Müller estimator [see Gasser and Müller (1979) ] or higher order local polynomial estimators [see Fan and Gijbels (1996) or Wand and Jones (1995) ]. It is also important to note that it is not necessary (and in many cases not desirable) that the number N used in the density step coincides with the sample size n. The summation over the index i can be considered as simple quadrature formula for the integral
and in cases, where this integral can be evaluated directly, a summation is in fact not necessary.
Because the kernel K d is positive by assumption the estimatep
I is obviously isotonic. Moreover, it is easy to see that the estimatorp
I is in some sense close to the function
(note that the kernel K d has compact support). In other words, the statisticp −1 I (α) is a consistent and smooth estimate of the effective dose level ED α
where the second equality follows from the strict monotonicity of the dose response curve p. If smoothing is not the main concern of the experimenter, the estimate
or an approximation by a quadrature formula could be used alternatively. Note that this estimate is continous (ifp is smooth), but not necessarily differentiable.
In the following discussion we make these heuristical arguments more precise. For this purpose we require the following assumptions regarding the bandwidths h r and h d in the regression and density estimate if the sample size n tends to infinity:
Note that in the case where the optimal bandwidth h r = γn −1/5 is used for the estimation of the regression function condition (2.9) gives h d n 2/5 → ∞ . The following Lemma gives the asymptotic bias and variance of the estimatep (2.13) and the constant κ 2 (K) is given by
Lemma 2.1. If the dose response curve is strictly increasing, conditions (2.5) -(2.9) and the assumptions stated at the beginning of this section are satisfied, then we have for any
Note that it follows from assumption (2.7) that the bias of the estimatep −1 I is asymptotically given by
and that the asymptotic variance ofp
I has a similar structure as the variance of the common local linear estimator of a regression function [see e.g. Wand and Jones (1995) ]. Our next theorem shows that the new estimator is asymptotically normal distributed. Gasser, Müller and Mammitzsch (1985) ], that a local polynomial estimator of order s − 1 is used for the regression estimatep [see Wand and Jones (1995) or Fan and Gijbels (1996) ], and assume that the dose response curve is s-times continuously differentiable, then a similar calculation as given in the proof of Lemma 2.1 shows
Theorem 2.2. If the dose response curve is strictly increasing, conditions (2.5) -(2.9) and the assumptions stated at the beginning of this section are satisfied, then we have for any
where
r is the asymptotically equivalent kernel corresponding to the local polynomial estimatorp [see Wand and Jones (1995) or Fan and Gijbels (1996) ]. Moreover, the statement of asymptotic normality remains valid for this type of estimator, where the kernel K r in the asymptotic variance (2.13) has to be replaced by K * r .
Remark 2.4. Müller and Schmitt (1988) proposed an alternative approach for estimating the effective dose level at some point α. These authors used a monotonized kernel estimate of the 5 dose response curve [see Brunk (1955), or Barlow, Bartholomew, Bremner and Brunk (1972) Müller and Schmitt (1988) shows that the first order asymptotic properties of both estimates are exactly the same. Note also that (p
) and consequently both terms in (2.12) are of the same sign. Therefore the bias of the estimatorp −1 I is slightly larger (depending on the order of h d ) than the bias of the estimator of Müller and Schmitt (1988) , which is given by Remark 2.5. Although the new estimate and the estimate of Müller and Schmitt (1988) are asymptotically equivalent, there are some differences with respect to the practical performance of both procedures. First, the isotonized estimate of the dose response curve introduced by the lastnamed authors is not necessarily strictly isotone, which provides some difficulties in its numerical inversion [for a possible solution see Müller and Schmitt (1988) or Section 3 of the present paper, where a different approach is presented]. Secondly, the estimate of Müller and Schmitt (1988) cannot be calculated for any α ∈ (p(0), p(1)), because it is not guaranteed that the range of isotonized kernel estimate of the dose response curve covers the whole interval (p(0), p(1)). For large sample sizes this phenomenon is negligible [provided that α ∈ (p(0), p(1))], however for small and moderate sample sizes some problems could appear if estimation of the extreme effective dose levels is of interest. The new estimatep
−1 I avoids this problem by its different construction and yields estimates for any α ∈ (p(0), p(1)).
Remark 2.6. Note that the new approach also provides simple estimates for the derivative of the effective dose level curve. For example,
u 1−α/2 denotes the (1 − α/2)-quantile of the standard normal distribution and
is an estimate of the asymptotic bias, which can be omitted, if h r = o(n −1/5 ) (note that h d = o(h r ) by assumption).
3 Finite sample properties
In this section we investigate the finite sample properties of the new estimatorp −1 I for the effective dose levels. For the regression estimatep we use a local linear estimator with Epanechnikov kernel based on a uniform design (f ≡ 1), where the bandwidth h r is chosen aŝ
2 denotes the estimator of Rice (1984) that iŝ
Note that this statistic converges almost surely to the quantity
[see Müller and Schmitt (1988) ], which appears in the asymptotically optimal global bandwidth
for the estimation of the dose response curve under the uniform design. For the bandwidth h d we consider two cases, namely h d = h β r , where β = 1.2 and β = 2.0. For the sake of comparison we also investigate a version of the estimator introduced by Müller and Schmitt (1988) . More precisely we used the PAVA [Pool-Adjacent-Violators Algorithm, see Barlow, Bartholomew, Bremner and Brunk (1972) ] to obtain an isotone estimate for the dose response curve. This estimate was then smoothed by a local linear estimator with bandwidthĥ r in order to obtain a strictly isotonic and smooth estimate [see Mammen (1991) ]. The final estimate which will be denoted byp −1 I throughout this section is obtained by a numerical inversion of this function. We investigate the binary response model (1.2) with a uniform design (f ≡ 1) and the link functions
which have also been considered by Müller and Schmitt (1988) . The sample size is n = 48, while the local linear estimate was evaluated N = 101 points. 1000 simulation runs were performed for each scenario. In Figure 1 -4 we present plots of the simulated bias, variance and mean squared error (mse) if α varies in the interval
This guarantees the existence of p −1 (α) theoretically and the PAVA estimator can be calculated in most cases. We observe that there is no clear ordering between the different competitors. A comparison of the estimatorsp I yields a smaller mse for a broad range of α, while the situation is less clear in model (3.6), where different estimators have to be preferred in different regions for the effective dose level. We finally note that in most cases the estimatorp −1 I yields a smaller mean squared error at the boundary of the interval E. In most cases considered in our study the estimators behave very similar, which confirms the asymptotic results presented in Section 2. In many cases the new estimates have a slightly smaller variance at the cost of a slightly larger bias. Usually the new estimates yield a smaller mse at the boundary of E and in the other regions of E the statisticp I proposed in this paper we recommend its application if the effective dose level curve has to be estimated nonparametrically.
Example 3.1. Lee (1974) used the logistic regression model to determine characteristics associated with remission of cancer patients. The explanatory variable was the labeling index (LI), which measures proliferative activity of cells after a patient received an injection of tritiated thymidine [see also Agresti (1990) for a table of the data]. This index varies between 8 and 38 and the binary response variable measures if a patient received remission. There were 27 patients in the study, and under the assumption of a logistic regression model the estimate of the ED 50 is given by 26.05 [Agresti (1990) ]. The LI was linearly transformed to the interval [0, 1] , where the different estimators of the ED 50 were applied. Finally the inverse linear transformation was applied to these estimates in order to obatin the estimates of the ED 50 in the original scale. The bandwidth h r for the initial local linear estimate was chosen according to the rule of thumb (3.1), that is h r ≈ 0.3557 and this bandwidth was also used for the smoothing of the PAVA estimate. Finally the bandwidth h d in the density step was chosen as h d = h 2 r ≈ 0.1265. In Figure 5 we present plots of the estimates for the effective dose level curve obtained from the logistic regression, the PAVA estimator and the new estimatorp of the ED 50 give very similar results, that is 21.78 and by 21.57, respectively. The nonparametric estimators of the ED α behave very similar, if α < 50% or α > 70%, while there are more differences if α varies in the interval [60%, 70%] . Moreover, the parametric and nonparametric methods yield rather different results for the estimation of the ED α in general, which indicates that the fit of the logistic regression model might not be appopriate for this data.
Appendix: proofs
For the sake of a transparent notation we assume that the number of design points N in the estimatê p −1 I equals the sample size n. The general case can be obtained exactly in the same way with an additional amount of notation using assumption (2.8).
Proof of Lemma 2.1.
We use the decomposition
where the (non-random) function p −1 n is defined by
and the remainder Δ n is given by
Recall the definition of the local linear estimatê
and
For the term (A.3) it follows that
4 ]. The asymptotic normality now follows from (A.21) and the central limit theorem of Ljapunoff. 
